Breaking AI & Tech News Analyzed

The Ban on Lex Greensill Lex Greensill, the disgraced former financier, has been banned from running a UK company for nine years following the 2021 collapse of his £1.6bn supply chain invoicing firm, Greensill Capital. The Collapse of Greensill Capital Greensill Capital collapsed into administration in March 2021 with liabilities of more than £1.6bn. The firm's collapse led to a significant financial scandal, involving former Prime Minister David Cameron and Japanese investor Masayoshi Son. The Insolvency Service's Findings The Insolvency Service found that Greensill breached his legal duty to exercise reasonable care, skill, and diligence as a company director, causing a loss of $440m to Credit Suisse. Greensill directed his companies to enter transactions that removed legal protections from loan notes, despite lacking the required written consents. The Impact of the Collapse The collapse of Greensill Capital caused chaos for companies owned by Sanjeev Gupta's Gupta Family Group (GFG) Alliance, which had relied heavily on Greensill financing. The UK's Serious Fraud Office is investigating suspected fraud, fraudulent trading, and money laundering related to GFG's financing arrangements with Greensill Capital. The Future Outlook Greensill still faces a separate civil action by administrators for Greensill Capital (UK), in which he is named as a defendant. The nine-year ban on Greensill running UK companies reflects the serious nature of his conduct and serves as a warning to other company directors.

Breakthrough Cancer Drug Reveals Hidden TumorsA smart drug that stops cancer cells "hiding" from treatment can shrink tumours by at least 30% in six of the world's most common forms of the disease, according to early trial results. While immunotherapy treatments have improved survival rates for many patients, their effectiveness can stall or fail when tumour cells hide and then spread.How the Smart Drug WorksResearchers in Oxford have developed a drug designed to stop cancer cells concealing themselves from the immune system, allowing immunotherapy treatments to identify and destroy them. In a trial spanning the UK, France, Spain and Australia, 83 patients with cervical, bladder, liver, bowel, lung or head and neck cancers were given the experimental drug, GRWD5769, alongside the immunotherapy treatment cemiplimab.The smart drug was able to remove "invisibility cloaks" from tumour cells, exposing them to the parts of the immune system that attack infections and diseases. This allowed the cemiplimab immunotherapy to pinpoint and destroy the cancer.Trial Results Across Cancer TypesResearchers, led by the Christie NHS foundation trust in Manchester, England, found that tumours shrank in 26 patients. Of those, 15 experienced tumour reductions of at least 30%. All participants had previously failed to respond to treatment, and most had no options left when they joined the study.GRWD5769 was shown to shrink tumours in all six cancer types included in the trial. The drug halted progression of the disease for at least six months in 18% of cervical cancer patients, 32% of liver cancer patients, 36% of bladder cancer patients, 38% of those with neck and head cancer, and more than half of bowel (51%) and lung (55%) cancer patients.Significance for Cancer TreatmentImmunotherapy enlists T-cells – immune system cells that attack infections and diseases – to hunt and destroy cancer. Although it has revolutionised cancer care, it fails in about two-thirds of patients. This is because immunotherapy struggles when tumours hide from the immune system.Tumours can evade the immune system by manipulating an enzyme called ERAP1 (endoplasmic reticulum aminopeptidase 1). By altering this enzyme, cancer cells can hide from a patient's T-cells. GRWD5769 solves this problem by inhibiting ERAP1, which removes cancer's invisibility cloak and makes tumour cells visible to T-cells that could not previously find them.Future Outlook for Cancer TreatmentThe findings were presented at the American Society of Clinical Oncology's annual meeting in Chicago, the world's largest cancer conference. Prof Fiona Thistlethwaite, the principal investigator, noted: "For a drug that is given as a tablet, this is very impressive. It's early days, and we need further studies, but this is a new drug with a new mechanism that clearly helps immunotherapy perform more effectively."The tablets, which were developed by Oxford-based Greywolf Therapeutics and were tolerated well by patients. The trial remains ongoing, with a larger study planned. Cancer Research UK's research information lead, Dr Samuel Godfrey, noted: "Immunotherapy has transformed treatment for some cancers but it doesn't yet work for everyone. This trial seems to show how this new drug could make immunotherapy more effective, including in some cases where immunotherapy had previously failed."

On Monday morning, a jury in Oakland, California, delivered a decisive victory to Sam Altman and OpenAI, dismissing Elon Musk's $150 billion lawsuit against the AI giant and its top executives. The Verdict in Oakland: A Procedural Victory for Altman The nine-member jury found that Musk had waited too long to bring his claims, ruling that the statute of limitations had expired before he filed the lawsuit in 2024. US District Judge Yvonne Gonzalez Rogers accepted the finding and dismissed the case, preventing the trial from addressing the core question of whether OpenAI betrayed its nonprofit mission. Verdict: Musk lost on procedural grounds (statute of limitations). Deliberation: Jury deliberated for less than two hours. Outcome: Case dismissed; no ruling on mission betrayal. The $150 Billion Dispute and OpenAI’s Valuation The trial centered on a financial and structural clash between two of Silicon Valley’s most powerful figures. While Musk sought to recover $150 billion, the case highlighted the immense scale of OpenAI's commercial success, which is reportedly valued at over $800 billion. Legal Claim: Musk sought $150 billion for alleged enrichment. Company Valuation: OpenAI valued at more than $800 billion. Timeline: Founding (2015) vs. Resignation (2018) vs. Lawsuit (2024). Why the Ruling Reshapes the AI Landscape This ruling removes a major legal threat for OpenAI at a pivotal moment. The company is deepening commercial partnerships and moving toward a potential public offering, a process that was previously clouded by Musk's legal challenges. However, the dismissal leaves the broader debate on AI governance unresolved. The trial never addressed critical issues such as transparency, data extraction, or how to govern superintelligent AI systems. The Road Ahead: Appeals and Unresolved Questions Musk has announced his intention to appeal, ensuring the feud will continue. The ruling clears the path for OpenAI's commercial expansion but does not settle the philosophical conflict over whether AI should prioritize profit or public benefit.

The Growing Opposition to Tech Support Cuts for Disabled StudentsDisability campaigners have launched a significant opposition to UK government plans that would remove funding for specialist assistive technology currently available to disabled students through the Disabled Students' Allowance (DSA). With nearly 10,000 people signing a petition against the proposed changes, the debate highlights tensions between technological advancement and specialized support needs in higher education.Department for Education Proposes Replacing Specialist Software with Free AlternativesThe Department for Education (DfE) has announced plans to withdraw funding for specialist assistive software currently provided as part of the Disabled Students' Allowance. According to the DfE, advances in technology mean that free, mass-market tools can now provide equivalent functionality to specialized software, except in "exceptional circumstances."The assistive software currently funded through DSA includes specialized tools for text-to-speech, speech-to-text, mind mapping, composition functions, as well as software to aid research, note-taking, and time and task management. These tools are individually assessed and clinically recommended based on specific student needs.The DfE maintains that students requiring support beyond what free tools can provide will continue to receive funded software through DSA, but critics argue this creates an unnecessary burden of proof for students who already face significant barriers to education.Financial Impact of Disabled Students' AllowanceThe Disabled Students' Allowance represents a substantial financial commitment, with more than 88,000 students benefiting in 2023-24 at a cost of £203 million. This funding has been crucial in providing equal educational opportunities for disabled students across higher education institutions in England.The proposed changes would redirect this funding away from specialized assistive technology toward more general solutions, potentially affecting the quality and effectiveness of support available to disabled students.Industry and Student Voices Oppose the Proposed ChangesThe British Assistive Technology Association (BATA) has strongly criticized the government's position, stating that free, general-purpose tools "do not provide equivalent functionality" to individually assessed, clinically recommended specialist tools. For many disabled students, these specialized technologies represent the difference between participating in higher education and being unable to do so at all.Student testimonials highlight the critical nature of these tools. Sam Wood, a second-year criminology student with severe visual impairment, explained that DSA-funded specialist tech "levels the playing field" by providing tools like Scholarcy and MindView that make academic materials accessible and manageable.Similarly, Helena Mok, a neuroscience student with fibromyalgia and ADHD, emphasized how specialized tools like Tailo provide tailored educational support that generic AI tools cannot match. "Asking a generic chatbot a scientific question just results in a long-winded, inaccurate wall of text," she noted.Industry voices also expressed concern. Chris Purcell, co-founder of assistive technology company CareScribe, described the proposed changes as "abandonment" that would strip away the adjustments making study possible and expose disabled students to avoidable failure.Future Outlook for Disabled Student Support in Higher EducationAs the government consultation on the proposed changes closes on June 18, the debate continues over the balance between technological advancement and specialized support needs. The outcome will likely have significant implications for disabled students' access to higher education and their ability to succeed academically and professionally.Disability advocates argue that while technological progress should be embraced, it should not come at the expense of specialized support that addresses the unique needs of disabled students. The petition and growing opposition suggest that the government may face considerable pressure to reconsider or modify its proposals.The long-term impact of any changes to the DSA could extend beyond higher education, potentially affecting employment opportunities and social inclusion for disabled individuals in the UK.

In a striking paradox, a senior academic from Western Sydney University used generative AI to author an opinion piece advising students against using technology to 'cut corners.' The article, published in the Sydney Morning Herald, has since been retracted for violating the publication's editorial standards.The Irony of the 'Do the Work' Op-EdProf Cath Ellis, the university’s pro-vice chancellor for quality and integrity, penned the piece in response to an article by academic Kylie Moore-Gilbert, who warned that students were essentially being graded on writing the best AI prompts. Ellis countered that students should 'do the work' and avoid outsourcing their thinking. However, subsequent testing using the AI-detector Pangram revealed the op-ed was 100% AI-generated.40,000 Words and a 100% AI Detection RateWhen confronted with the evidence, Western Sydney University defended Ellis's methodology. A spokesperson detailed the process:Ellis uploaded 40,000 words of her original academic materials into a Copilot Large Language Model (LLM).The LLM was used to summarize her knowledge and generate prompts for the early drafts.The university classified this as a 'sophisticated and appropriate use' of AI, arguing that detection tools cannot distinguish between ethical and unethical AI usage.Media Policies Collide with AI RationalizationDespite the university's defense, the incident directly violated the editorial policy of Nine, the parent company of the Sydney Morning Herald. While Nine permits AI for initial research, it strictly prohibits using AI to write stories for publication without clear labeling. SMH editor Jordan Baker confirmed the article was removed, stating the publication was not informed of the AI usage by Ellis or the university, calling the omission 'unacceptable.'The Inevitable Transparency Mandate in JournalismThis incident highlights a growing crisis in media integrity. Recent months have seen similar controversies, including Crikey removing AI-assisted articles and the New York Times severing ties with a freelancer who used AI for a book review. As generative tools become ubiquitous, news organizations will likely be forced to implement zero-tolerance transparency mandates, requiring explicit disclosures for any AI-assisted drafting, regardless of how much original human input was provided to the prompt.

The Lead: Australia's Comeback VictoryNathan Ellis starred with the ball as Australia dismissed Pakistan for 190 to level the the one-day international series in Lahore with a victory by 41 runs.The Sydney-born quick claimed opener Maaz Sadaqat for a duck and then sent the dangerous-looking Babar Azam back to the sheds for 16 to leave the hosts struggling.Ellis's Four-Wicket TornadoHe finished with 4-33 with Matthew Short chipping in with 3-36 as the Pakistan reply petered out. The Australian bowler's performance was crucial in restricting Pakistan after the hosts had looked to build a substantial chase.Australian Batting ResilienceEarlier, Josh Inglis and Cameron Green hit fighting half centuries to help Australia post 231-9. Green knocked a polished 92-ball 53 while Inglis scored a 74-ball 51 to counter another spin test on a dry Gaddafi Stadium pitch after the visitors were put in to bat by Pakistan.The Green-Inglis duo lifted Australia from 51-3 with a sedate 51-run stand after Pakistan attacked with the spin as early as from the fifth over.Spin Challenge OvercomeIt was pacer Shaheen Shah Afridi who bowled opener Alex Carey with the first ball of the match before spinners Abrar Ahmed and Arafat Minhas struck once each, removing Matthew Short (15) and Marnus Labuschagne for five respectively.Inglis hit five boundaries in his fifth ODI fifty before he was bowled by Minhas in the 27th over. Minhas, who took five wickets on debut in Pakistan's five-wicket win in the first ODI in Rawalpindi on Saturday, finished with 2-27.Series ImplicationsGreen added another invaluable 65 runs for the fifth wicket with Matthew Renshaw (43) before Abrar removed Green to push the visitors hard. Green's third ODI half century had a single boundary and two sixes.Oliver Peake ensured Australia post a fighting total with a brisk 32-ball 31 inclusive of two sixes and a boundary. Shaheen was the best home bowler with 3-36.

The scheduled June 9 pre‑World Cup friendly between the Democratic Republic of Congo and Chile was abruptly cancelled after La Línea de la Concepción’s mayor, Juan Franco, signed a decree citing Ebola‑related health risks.Mayor’s Decisive Ban on the June 9 FriendlyFranco announced the cancellation as a precautionary measure, following recommendations from the Andalusia regional health service and the town’s own medical director. La Línea, a town of about 65,000 residents near the Gibraltar border, deemed the health threat too great to host an international match.Health‑Driven Cancellation in La Línea de la ConcepciónMayor Juan Franco signed the decree on June 2.The municipal health chief issued a categorical advisory against the match.The decision aligns with regional government guidance on the Ebola outbreak in eastern DR Congo.Numbers Behind the Decision: Population, Dates, and Isolation RulesTown population: 65,000.Match date that was to be held: June 9.U.S. authorities require the DR Congo squad to isolate for 21 days before entering the United States.Ripple Effects on DR Congo’s World Cup PreparationsThe African side had already abandoned a home training camp after the outbreak was declared in mid‑May. Instead, the team relocated to Belgium, where it will face Denmark in Liège on Wednesday. The cancellation removes a key test against South American opposition and compresses the squad’s preparation window before their Group K opener in Houston on June 17.What’s Next for the Team and the Tournament?With the friendly scrapped, DR Congo will likely seek alternative low‑risk matches in Europe to fine‑tune tactics. The broader lesson for organizers is heightened vigilance on health protocols, especially for teams traveling from regions with active outbreaks. Stakeholders will monitor whether any further fixtures are adjusted as the tournament progresses.

The Lead The narrative that BP's boardroom drama is a sign of the company's continued dysfunction is overly simplistic. The removal of chair Albert Manifold after just eight months in post may actually be a sign of the board doing what it's supposed to do. The Event Details The board considered 'serious concerns' raised against Manifold related to 'important governance standards, oversight and conduct'. They deemed his conduct 'unacceptable' and removed him, rather than smoothing things over. This was not a disagreement over strategy, but a response to whistleblowing concerns. The Data Analysis No specific data was provided, but the article notes that Manifold had been a highly successful CEO of CRH, an Irish building materials group. His appointment as chair was seen as a way to inject results-focused vigour into BP. The Impact Analysis The removal of Manifold may actually be a positive sign for BP's governance. It shows that the board is willing to take tough decisions and confront problems promptly. This could help to restore confidence in the company's leadership. The Prediction Assuming new CEO Meg O'Neill can deliver on her promise of a 'simpler, stronger, more valuable company', there is no reason why the damage from Manifold's removal should be permanent. The key will be to appoint a new chair who measures up to the task.

The Lead: A Literary Vision Brought to LifeHere is an adaptation, written by Justine Waddell, of Virginia Woolf's peculiar and tonally elusive work that is all about the quarterlife crisis of a headstrong, well-born young woman in Edwardian London faced with the necessity of getting married. What emerges is a wayward, unworldly fantasia, a four-leaf clover of a film – or even five-leaf; rather beautifully designed and photographed, flavoured with a wistful, unexpectedly Germanic kind of romanticism.The Event Details: A Creative ReimaginingWaddell and Iranian-born director and Bafta nominee Tina Gharavi have creatively gone against the grain of the novel, amplifying Woolf's single glancing reference to astronomy and making that the centre of the heroine's yearning, perhaps playfully implanting a subconscious memory of Cole Porter's lyrics to the song of the same title: "You are the one, only you beneath the moon, under the sun …." And – thankfully, in my view – the film removes Woolf's supercilious condescension towards the self-betterment of newly educated lower and middle classes, and instead focuses on a sweet-natured story, performed with conviction by its all-star ensemble cast, interspersed with dreamlike set pieces. The result is not precisely Virginia Woolf's Night and Day; maybe more EM Forster's Night and Day or even Ronald Firbank's Night and Day.The Data Analysis: Cast and Release InformationWith spirit and charm, Haley Bennett plays headstrong young Katharine Hilbery, the only child of wealthy parents (Timothy Spall and Jennifer Saunders), who are burdened by the reputation of Katharine's late grandfather, an illustrious poet and critic like a B-division Ruskin or Carlyle, whose unwieldy biography her mother is in fact trying to write. Katharine is a self-taught astronomer trying to gain admission to the University of Cambridge to read maths, and battling academia's anti-women attitudes (women students were being refused degrees in those days even if they were admitted).The Impact Analysis: A New Perspective on WoolfRealising that her intellectual ambitions are only possible as a married woman, Katharine impulsively gets engaged to her clueless childhood friend William Rodney, amusingly played by Jack Whitehall: Rodney is a complete chump of a man who writes insufferable essays about Elizabethan poetry and Sir Philip Sidney's Astrophel and Stella. But it is at this moment Katharine realises she might have feelings for Ralph Denham (Elyas M'Barek), the young writer that her mother has hired as her personal secretary to edit that sprawling biography.The Prediction: Future of the AdaptationVirginia Woolf's Night and Day screened at SXSW London; it is in UK and Irish cinemas from 19 June and is released in the US later this year. It is such a sweet story and guilelessly eccentric – a butterfly fluttering just beyond the wheel of realism.